About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01315054

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patient...

Lead sponsor: Centers for Disease Control and Prevention•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centers for Disease Control and Prevention

Collaborators

National Center for AIDS/STD Control and Prevention, China CDC

Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However，the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•client participants will include both men and women who are opiate-dependent drug users who started MMT not more than one month prior to enrollment in the study
•18 years of age or older
•residing in the study areas

Related studies

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more

RECRUITINGPhase 1

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

NCT07392372 · HIV -1 Infection

An Effectiveness Trial of the PrEP for WINGS Study

NCT06853314 · HIV Infections, Alcohol Use Disorder, and more

Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75

NCT07388394 · Virus-HIV

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT06444360 · HIV

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 22, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment4,258

Start dateMay 2011

Last updatedAug 22, 2024

Condition

HIV Hepatitis C Syphilis Herpes Simplex Type II

Locations shown

National Center for HIV/STD Prevention and Control, China CDC

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions